Regulation of mesenchymal cells by epithelial Wnt ligands

NIH RePORTER · NIH · R01 · $608,155 · view on reporter.nih.gov ↗

Abstract

PROJECT SUMMARY Alveologenesis requires co-development of the epithelium, mesenchyme, and vasculature, the failure of which is a cardinal feature of bronchopulmonary dysplasia (BPD). This process depends on precisely controlled intercellular signaling, such as Fgf, Pdgf, Shh, and Vegf signaling, as revealed by recent work including ours in the previous grant period. Another major signaling pathway, Wnt signaling, extensively studied in embryonic lungs and potentially involved in adult lungs, is poorly understood in the neonatal period. Moreover, published Wnt studies focus on epithelial cells, but largely ignore the robust expression of Wnt target genes within the postnatal mesenchyme. Further contributing to our limited understanding of mesenchymal Wnt signaling is lack of clarity on the cell types in the mesenchyme, which starts to be unveiled via single-cell genomics. By following the unexpected signaling role of AT1 cells in the previous grant period, we have obtained evidence that epithelial WNT ligands specifically signal toward myofibroblasts during alveologenesis. Pursuing, as proposed, the signaling cells (Aim 1), the receiving cells (Aim 2), and the disease relevance (Aim 3) is expected to not only elucidate the little-known mesenchymal Wnt signaling, but also establish an experimental paradigm applicable to future lung mesenchyme research.

Key facts

NIH application ID
10122223
Project number
2R01HL130129-06
Recipient
UNIVERSITY OF TX MD ANDERSON CAN CTR
Principal Investigator
Jichao Chen
Activity code
R01
Funding institute
NIH
Fiscal year
2021
Award amount
$608,155
Award type
2
Project period
2016-03-01 → 2025-06-30